コンテンツへスキップ

Synthesis and preliminary ex vivo evaluation of the spasmolytic activity of 1,3-thiazolium- and 1,3,4-thiadiazolium-5-methylthio- and 5-thioacetate derivatives.

Synthesis and preliminary ex vivo evaluation of the spasmolytic activity of 1,3-thiazolium- and 1,3,4-thiadiazolium-5-methylthio- and 5-thioacetate derivatives.

Acta pharmaceutica (Zagreb, Croatia) (2014-06-11)

José A S Luis, Thiago M De Aquino, Bruno F Lira, Petrônio F A Filho, Marcus T Scotti, Luciana Scotti, Ricardo O De Moura, Francisco J B Mendonça Junior

要旨

Seven new compounds have been synthetized in satisfactory yields (51-78 %) through the treatment of mesoionic 1,3-thiazolium-5-thiolate (4a-d) and 1,3,4-thiadiazolium- 5-thiolate (10a,b) with chloroacetic acid or methyl iodide: 1,3,4-thiadiazolium-5-methylthio- (11) and 5-thioacetate (12). The structure of the title compounds was elucidated by elemental analysis, IR, (1)H and (13)C NMR spectroscopy. The newly synthesized compounds 5a, 6a, 11 and 12 were evaluated for their ex vivo spasmolytic potential on four isolated smooth muscles (rat aorta and uterus, guinea pig ileum and trachea) and compared with scopolamine. Some of the compounds exhibited potent spasmolytic activity equal to or stronger than scopolamine.

材料

製品番号

ブランド

製品内容

Sigma-Aldrich

酸化アルミニウム, Brockmann I, standard grade, activated, basic

Sigma-Aldrich

酸化アルミニウム, activated, Brockmann I, standard grade, neutral

Sigma-Aldrich

アセチルコリンクロリド, ≥99% (TLC)

Sigma-Aldrich

酸化アルミニウム, powder, 99.99% trace metals basis

Sigma-Aldrich

酸化アルミニウム, Brockmann I, standard grade, activated, acidic

Sigma-Aldrich

酸化アルミニウム, powder, primarily α phase, ≤10 μm avg. part. size, 99.5% trace metals basis

Sigma-Aldrich

酸化アルミニウム, nanopowder, <50 nm particle size (TEM)

Sigma-Aldrich

アラキドン酸, >95.0% (GC)

Sigma-Aldrich

アラキドン酸, from non-animal source, ≥98.5% (GC)

Sigma-Aldrich

酸化アルミニウム, nanoparticles, <50 nm particle size (DLS), 20 wt. % in isopropanol

Sigma-Aldrich

オキシトシン, lyophilized powder, ~15 IU/mg solid (Prepared from synthetic oxytocin)

Sigma-Aldrich

オキシトシン

Sigma-Aldrich

塩化カルバモイルコリン, ≥98% (titration), crystalline

Sigma-Aldrich

酸化アルミニウム, Corundum, α-phase, -100 mesh

Sigma-Aldrich

酸化アルミニウム, pellets, 3 mm

Sigma-Aldrich

酸化アルミニウム, fused, powder, primarily α-phase, -325 mesh

Sigma-Aldrich

酸化アルミニウム, nanopowder, 13 nm primary particle size (TEM), 99.8% trace metals basis

Sigma-Aldrich

アセチルコリンクロリド, suitable for cell culture

Sigma-Aldrich

酸化アルミニウム, 99.997% trace metals basis

USP

オキシトシン, United States Pharmacopeia (USP) Reference Standard

Sigma-Aldrich

酸化アルミニウム, Type WN-6, Neutral, Activity Grade Super I

Sigma-Aldrich

酸化アルミニウム, pore size 58 Å, ~150 mesh

Sigma-Aldrich

酸化アルミニウム, nanoparticles, 30-60 nm particle size (TEM), 20 wt. % in H₂O

Sigma-Aldrich

酸化アルミニウム, fused, powder, primarily α-phase, 100-200 mesh

Sigma-Aldrich

酸化アルミニウム, single crystal substrate, <0001>

Sigma-Aldrich

酸化アルミニウム, nanowires, diam. × L 2-6 nm × 200-400 nm

Sigma-Aldrich

酸化アルミニウム、メソポーラス, MSU-X (wormhole), average pore size 3.8 nm

Sigma-Aldrich

酸化アルミニウム, standard grade, activated, Brockmann I, neutral, free-flowing, Redi-Dri^™

Sigma-Aldrich

アセチルコリンクロリド, pkg of 150 mg (per vial)

Sigma-Aldrich

酸化アルミニウム, Brockmann I, activated, standard grade, free-flowing, Redi-Dri^™